LENSAR, Inc. Appoints Gary Winer to the Board of Directors
September 06, 2018 at 01:07 pm
Share
LENSAR, Inc. announced global healthcare senior executive Gary Winer has joined the company’s board of directors, effective immediately. With more than 20 years in leadership positions in the healthcare and pharmaceutical industries, Gary Winer has been tapped by Fortune 100 companies to manage blockbuster product lines and introductions in the United States, Latin America, Asia, and Japan.
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
LENSAR, INC. 
